As a resident, I had the opportunity to take care of a young woman with an ovarian germ cell tumor. She initially presented to an outside facility with an ovarian cyst believed to be benign. Following a cystectomy at this facility where the frozen pathologic specimen was determined benign, the final pathology unexpectedly returned as malignant. She then presented to the University of Chicago oncology service for a second opinion. She underwent conservative surgery with unilateral salpingo-oophorectomy and lymph node sampling, and the contralateral ovary and uterus were grossly normal and preserved. This fertility-preserving surgery is standard of care for women with germ cell tumors confined to one ovary that have not completed childbearing. She was to return to the inpatient chemotherapy service for her BEP (bleomycin, etoposide, and cisplatin) regimen following recovery from the surgery.
ask the necessary questions, even if the patients seem knowledgeable. The false security the medical profession feels when patients do not inquire is dangerous in that it leaves our patients relying on alternative sources for their information. Fertility preservation discussions can occur at all levels of our health care system from nurses to medical students to residents to fellows as well as attending physicians. As a current reproductive endocrine fellow, I hope to pass on this lesson to those clinicians currently on the front lines of cancer care.
